Comparative effectiveness and cost-effectiveness of the implantable miniature telescope

Ophthalmology

Volumn 118, Issue 9, 2011, Pages 1834-1843

  Brown, Gary C ^a,b,c   Brown, Melissa M ^a,b,c,d   Lieske, Heidi B ^a   Lieske, Philip A ^a   Brown, Kathryn S ^a   Lane, Stephen S ^e  

^a CENTER FOR VALUE BASED MEDICINE   (United States)

^b Eye Research Institute   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CATARACT EXTRACTION; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; PRIORITY JOURNAL; PROSTHESIS; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RETINA MACULA AGE RELATED DEGENERATION; TELESCOPE PROSTHESIS; VISION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ARTIFICIAL ORGANS; BIOCOMPATIBLE MATERIALS; CLINICAL TRIALS AS TOPIC; CORNEA; COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH CARE COSTS; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 80052550474     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.02.012     Document Type: Article

References (50)

1. R. Klein, B.E. Klein, and S.C. Tomany Ten-year incidence and progression of age related maculopathy: The Beaver Dam Eye Study Ophthalmology 109 2002 1767 1779
2. Eye Diseases Prevalence Research Group Prevalence of age-related macular degeneration in the United States Arch Ophthalmol 122 2004 564 572
3. P.J. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431 (Pubitemid 44511557)
4. D.M. Brown, P.K. Kaiser, M. Michels ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444 (Pubitemid 44511558)
5. M.M. Brown, G.C. Brown, H.C. Brown, and J. Peet A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration Ophthalmology 115 2008 1039 1045
6. Age-Related Eye Disease Study Research Group A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and visual loss: AREDS report no. 8 Arch Ophthalmol 119 2001 1417 1436
7. H.L. Hudson, S.S. Lane, J.S. Heier IMT-002 Study Group Implantable miniature telescope for the treatment of visual acuity loss resulting from end stage age-related macular degeneration: 1-year results Ophthalmology 113 2006 1987 2001 (Pubitemid 44635735)
8. H.L. Hudson, R.D. Stulting, J.S. Heier IMT002 Study Group Implantable telescope for end-stage age-related macular degeneration: long-term visual acuity and safety outcomes Am J Ophthalmol 146 2008 664 673
9. K.A. Colby, D.F. Chang, R.D. Stulting, and S.S. Lane Surgical placement of an optical prosthetic device for end stage macular degeneration: the implantable miniature telescope Arch Ophthalmol 125 2007 1118 1121 (Pubitemid 47258046)
10. Barack Obama's plan for a healthy America: lowering health care costs and ensuring high-quality affordable health care for all http://www.barackobama. com/pdf/HealthPlanFull.pdf Accessed December 5, 2010
11. Open Congress for the 111th United States Congress H.R.3590 - Patient Protection and Affordable Care Act http://www.opencongress. org/bill/111-h3590/ text Accessed December 5, 2010
12. M.R. Gold, D.L. Patrick, and G.W. Torrance Identifying and valuing outcomes M.R. Gold, J.E. Siegel, L.B. Russell, M.C. Weinstein, Cost-Effectiveness in Health and Medicine 1996 Oxford University Press New York 82 134
13. National Institute for Health and Clinical Excellence Guideline Development Methods Incorporating health economics in guidelines and assessing resource impact (revised) http://www.nice.org.uk/niceMedia/pdf/GDM-Chapter8-030. pdf 2007 Accessed July 15, 2010
14. M.M. Brown, G.C. Brown, and S. Sharma Evidence-Based to Value-Based Medicine 2005 AMA Press Chicago, IL 151 266
15. J.E. Siegel, M.C. Weinstein, L.B. Russell, M.R. Gold Panel on Cost-Effectiveness in Health and Medicine Recommendations for reporting cost-effectiveness analyses JAMA 276 1996 1339 1341 (Pubitemid 26346934)
16. VisionCare Ophthalmic Technologies VisionCare's Implantable Miniature Telescope (by Dr. Isaac Lipshitz) An intraocular telescope for treating severe to profound vision impairment due to bilateral end-stage age-related macular degeneration. Patient information booklet May 5, 2010 20 39 http://www. accessdata.fda.gov/cdrh-docs/pdf5/P050034c.pdf Accessed December 4, 2010
17. National Quality Measures Clearinghouse Measure validity Using the NQMC Template of Measure Attributes to Assess the Validity of Measures http://qualitymeasures.ahrq.gov/selecting-and632using/validity.aspx Accessed December 17, 2010
18. S. Sharma, G.C. Brown, and M.M. Brown Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients Br J Ophthalmol 86 2002 493 496 (Pubitemid 34454489)
19. M.M. Brown, G.C. Brown, S. Sharma, and G. Shah Utility values and diabetic retinopathy Am J Ophthalmol 128 1999 324 330 (Pubitemid 29413229)
20. S. Sharma, G.C. Brown, and M.M. Brown Converting visual acuity to utilities Can J Ophthalmol 35 2000 267 272
21. G.C. Brown Vision and quality-of-life Trans Am Ophthalmol Soc 97 1999 473 511 (Pubitemid 30106064)
22. G.C. Brown, S. Sharma, M.M. Brown, and J. Kistler Utility values and age-related macular degeneration Arch Ophthalmol 118 2000 47 51 (Pubitemid 30036436)
23. M.M. Brown, G.C. Brown, and S. Sharma Utility values associated with blindness in an adult population Br J Ophthalmol 85 2001 327 331 (Pubitemid 32250764)
24. M.M. Brown, G.C. Brown, and S. Sharma Quality-of-life associated with unilateral and bilateral good vision Ophthalmology 108 2001 643 647 (Pubitemid 32238453)
25. M.M. Brown, G.C. Brown, and S. Sharma Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration Arch Ophthalmol 120 2002 481 484 (Pubitemid 34727820)
26. Social Security Online Actuarial Publications. Period Life Table, 2006 http://www.ssa.gov/OACT/STATS/table4c6.html Accessed December 5, 2010
27. Center for Medicare and Medicare Services Physician Fee Schedule Search https://www.cms.gov/apps/physician-fee-schedule/search/search-criteria.aspx Accessed January 23, 2011
28. Centers for Medicare and Medicaid Services Anesthesia Work, Practice Expense (PE), and Malpractice (MP) Shares http://www.cms.gov/PhysicianFee Sched/downloads/AnesthesiaSharesCY2011.pdf Accessed January 23, 2011
29. Department of Health and Human Services Centers for Medicare & Medicaid Services, Centers for Medicare and Medicaid Services Addendum AA.Final ASC Covered Surgical Procedures for CY 2010;1463 http://www.ascassociation.org/ 2010.pdf Accessed January 23, 2011
30. Department of Health and Human Services Centers for Medicare & Medicaid Services Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2010:1466 http://www.mgma.com/ WorkArea/DownloadAsset.aspx?id=30691 Accessed January 23, 2011
31. Centers for Medicare and Medicaid Services Physician Fee Schedule Search HCPCS Code 97110 http://www.cms.gov/apps/physician-fee-schedule/search/search- results.aspx?Y=1&T=0&HT=0&CT=3&H1=97110&M=5 Accessed January 23, 2011
32. Drug Shop Online Maxitrol (Neomycin) eye drops 5 ml http://www. drugshoponline.com/Buy-Eye-Drops-MAXiTROL-(NEOMYCiN)-Eye-Drops-5ml.html Accessed July 11, 2010
33. Ambulatory Surgical Center Association Medicare's 2010 ASC Payments: Rates and Policies http://www.ascassociation.org/medicare2010/ Accessed July 9, 2010
34. ASC Campaign for Advancing Surgical Care Statement by Chris Holden http://energycommerce.house.gov/Press-111/20100506/Holden. Testimony.05.06.2010. pdf Accessed July 10, 2010
35. J.C. Javitt, Z. Zhou, and R.J. Willke Association between vision loss and higher medical care costs in Medicare beneficiaries: costs are greater for those with progressive visual loss Ophthalmology 114 2007 238 245
36. Bureau of Labor Statistics CPI Detailed Report Data for January 2010. Table 29;130 http://www.bls.gov/cpi/cpid1001.pdf Accessed January 23, 2011
37. J.D. Stein, M.M. Brown, and G.C. Brown Quality of life with macular degeneration: perceptions of patients, clinicians, and community members Br J Ophthalmol 87 2003 8 12 (Pubitemid 36071770)
38. G.C. Brown, M.M. Brown, and P. Kertes Value-based medicine, cost-utility analysis: the value of commonly used pharmaceuticals Evid Based Ophthalmol 10 2009 61 66
39. M.M. Brown, G.C. Brown, and H.C. Brown Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome Arch Ophthalmol 127 2009 146 152
40. G.C. Brown, M.M. Brown, and H.C. Brown A value based medicine comparison of interventions for subfoveal neovascular macular degeneration Ophthalmology 114 2007 1170 1178 (Pubitemid 46829369)
41. B. Busbee, M.M. Brown, G.C. Brown, and S. Sharma Incremental cost-effectiveness of initial cataract surgery Ophthalmology 109 2002 606 612 (Pubitemid 34184933)
42. A. Laupacis, D. Feeny, A.S. Detsky, and P.X. Tugwell How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations CMAJ 146 1992 473 481
43. G.R. Heudebert, R.M. Centor, and J.C. Klapow What is heartburn worth? A cost-utility analysis of management strategies J Gen Intern Med 15 2000 175 182 (Pubitemid 30155350)
44. D.F. Kallmes, and M.H. Kallmes Cost-effectiveness of angiography performed during surgery for ruptured intracranial aneurysms AJNR Am J Neuroradiol 18 1997 1453 1462 (Pubitemid 30413960)
45. National Institute for Health and Clinical Excellence The Guidelines Manual 2009 Assessing cost-effectiveness http://www.nice.org.uk/media/68D/29/ The-guidelines-manual-2009-Chapter-7-Assessing-cost-effectiveness.pdf Accessed December 17, 2010
46. World Health Organization The World Health Report 2002 Reducing Risks, Promoting Healthy Life 2002 World Health Organization Geneva 108 http://www.who.int/whr/2002/en/whr02-en.pdf Accessed December 17, 2010
47. Central Intelligence Agency The World Factbook: North America: United States: Economy tab https://www.cia.gov/library/publications/the784 world-factbook/geos/us.html Accessed September 1, 2010
48. A.I. Mushlin, C. Mooney, and R.G. Holloway The cost-effectiveness of magnetic resonance imaging for patients with equivocal neurological symptoms Int J Tech Assess Health Care 13 1997 21 34 (Pubitemid 27138805)
49. G.C. Brown, M.M. Brown, and S. Sharma A cost-utility analysis of interventions for severe proliferative vitreoretinopathy Am J Ophthalmol 133 2002 365 372 (Pubitemid 34171587)
50. G.C. Brown, M.M. Brown, and H.C. Brown The comparative effectiveness and cost-effectiveness of intraocular 90Sr brachytherapy/intravitreal VEGF inhibitor for neovascular macular degeneration Evid Based Ophthalmol 10 2009 107 122